F/M Emerald Life Sciences Innovation ETFF/M Emerald Life Sciences Innovation ETFF/M Emerald Life Sciences Innovation ETF

F/M Emerald Life Sciences Innovation ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪68.82 M‬USD
Fund flows (1Y)
‪8.36 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
−0.04%
Shares outstanding
‪2.34 M‬
Expense ratio
0.54%

About F/M Emerald Life Sciences Innovation ETF


Issuer
1251 Capital Group, Inc.
Brand
F/m
Home page
Inception date
Oct 30, 2024
Structure
Open-Ended Fund
Index tracked
No Underlying Index
Replication method
Physical
Management style
Active
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
F/m Investments LLC
Distributor
Quasar Distributors LLC
ISIN
US74933W2219
LFSC seeks to invest in innovative life sciences companies that are expected to create value and long-term growth. The actively managed fund relies on a specialized and experienced team to research complex life sciences companies. It invests in US equity securities identified to have growth potential that meet the criteria of technological advancement, market disruption, or artificial intelligence. The broad life science field includes biotechnology, pharmaceutical, medical diagnostics and devices, healthcare services and technologies, and synthetic biology. Stock selection employs an extensive 10-step research process that includes reviews of publicly available and third-party information, peer reviews, financial and valuation models, internal research, surveys, as well as interviews and contact with management, industry and medical professionals, supply chain, and collaboration within the investment team. The fund may invest up to 20% in foreign companies listed on a US exchange.

Broaden your horizons with more funds linked to LFSC via country, focus, and more.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharma, biotech & life sciences
Strategy
Active
Geography
U.S.
Weighting scheme
Proprietary
Selection criteria
Proprietary
What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
90%6%3%
Top 10 holdings
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


An exchange-traded fund (ETF) is a collection of assets (stocks, bonds, commodities, etc.) that track an underlying index and can be bought on an exchange like individual stocks.
LFSC trades at 29.32 USD today, its price has fallen −0.60% in the past 24 hours. Track more dynamics on LFSC price chart.
LFSC net asset value is 29.33 today — it's risen 6.00% over the past month. NAV represents the total value of the fund's assets less liabilities and serves as a gauge of the fund's performance.
LFSC assets under management is ‪68.82 M‬ USD. AUM is an important metric as it reflects the fund's size and can serve as a gauge of how successful the fund is in attracting investors, which, in its turn, can influence decision-making.
LFSC price has risen by 5.29% over the last month, and its yearly performance shows a 17.19% increase. See more dynamics on LFSC price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 6.00% over the last month, showed a 18.40% increase in three-month performance and has increased by 25.44% in a year.
LFSC fund flows account for ‪8.36 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Since ETFs work like an individual stock, they can be bought and sold on exchanges (e.g. NASDAQ, NYSE, EURONEXT). As it happens with stocks, you need to select a brokerage to access trading. Explore our list of available brokers to find the one to help execute your strategies. Don't forget to do your research before getting to trading. Explore ETFs metrics in our ETF screener to find a reliable opportunity.
LFSC invests in stocks. See more details in our Analysis section.
LFSC expense ratio is 0.54%. It's an important metric for helping traders understand the fund's operating costs relative to assets and how expensive it would be to hold the fund.
No, LFSC isn't leveraged, meaning it doesn't use borrowings or financial derivatives to magnify the performance of the underlying assets or index it follows.
In some ways, ETFs are safe investments, but in a broader sense, they're not safer than any other asset, so it's crucial to analyze a fund before investing. But if your research gives a vague answer, you can always refer to technical analysis.
Today, LFSC technical analysis shows the buy rating and its 1-week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1-month rating LFSC shows the neutral signal. See more of LFSC technicals for a more comprehensive analysis.
No, LFSC doesn't pay dividends to its holders.
LFSC trades at a premium (0.04%).
Premium/discount to NAV expresses the difference between the ETF’s price and its NAV value. A positive percentage indicates a premium, meaning the ETF trades at a higher price than the calculated NAV. Conversely, a negative percentage indicates a discount, suggesting the ETF trades at a lower price than NAV.
LFSC shares are issued by 1251 Capital Group, Inc.
LFSC follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
The fund started trading on Oct 30, 2024.
The fund's management style is active, aiming to outperform its benchmark index by actively selecting and adjusting assets. The goal is to achieve returns that exceed those of the index the fund tracks.